Astrana Health, Inc. ASTH

Industrials SIC 8742 - Services-Management Consulting Services NAICS Professional, Scientific, and Technical Services › Management, Scientific, and Technical Consulting Services › Management Consulting Services › Administrative Management and General Management Consulting Services derived Nasdaq

Astrana is a leading physician-centric, technology-powered, risk-bearing healthcare company. Leveraging its proprietary end-to-end technology solutions, Astrana operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver accessible, high-quality care to patients in a cost-effective manner. We, together with our affiliated physician groups and consolidated subsidiaries and VIEs, provide coordinated outcome-based care, serving patients covered by private or public insurance provided through Medicare, Medicaid, and health maintenance organizations ("HMOs"), with a small portion of our revenue coming from non-insured patients. We provide care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Our physician network consists of primary care physicians, specialist physicians, physician and specialist extenders, and hospitalists. Astrana's common stock is listed on The Nasdaq Stock Market LLC ("Nasdaq") and trades under the symbol "ASTH."

Last close 37.45 2026-10-23
Market cap $2.09B 2026-06-30 share count
52-week range 18.08 - 51.60

Valuation FY2025 figures against the last close

P/S0.7x
P/E81.4x
P/FCF20.0x
EV/EBITDA21.7x
Dividend yield0.4%
Diluted EPS0.46

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $3.18B$2.03B$1.39B$1.14B$773.9M$687.2M$560.6M$519.9M$356.4M$305.9M
Cost of revenue ————$596.1M$539.2M$467.8M$361.1M$273.5M$254.8M
Gross profit ————$177.8M$148.0M$92.8M$158.8M$82.9M$51.2M
SG&A $217.3M$154.1M$112.6M$77.7M$62.1M$49.1M$41.5M$43.4M$26.2M$21.0M
Total operating expenses $3.10B$1.95B$1.30B$1.04B$675.7M$606.7M$528.2M$431.5M$321.2M$294.2M
Operating income $78.5M$89.3M$84.6M$104.3M$98.2M$80.5M$32.4M$88.4M$35.1M$11.7M
Interest expense $49.9M$33.1M$16.1M$7.9M$5.4M$9.5M$4.7M$561.0K$79.7K$61.6K
Pre-tax income $39.6M$80.8M$89.8M$86.6M$77.7M$178.4M$25.8M$82.6M$49.7M$18.8M
Income tax $15.5M$30.9M$32.0M$40.9M$31.7M$56.3M$8.2M$22.4M$3.9M$8.8M
Net income $24.0M$50.0M$58.0M$46.0M$46.0M$37.7M$14.1M$10.8M$25.8M$11.5M
EPS, basic 0.460.911.301.001.571.030.410.331.010.46
EPS, diluted 0.460.901.290.991.521.010.390.290.900.41
Shares, diluted (wtd. avg.) 49.4M48.0M46.9M45.6M45.4M37.4M36.4M37.9M28.7M28.0M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $429.5M$288.5M$293.8M$288.0M$233.1M$194.0M$104.0M$107.6M$118.5M$54.9M
Short-term investments —$2.4M$2.5M$5.6M$53.4M$67.7M$116.5M$1.1M$1.1M$1.1M
Receivables $374.5M$276.0M—$49.6M$10.6M$7.1M$11.0M$7.7M$7.6M$22.3M
Total current assets $863.3M$638.5M$461.5M$428.1M$472.0M$338.6M$329.1M$172.9M$144.2M$81.2M
Property, plant and equipment $57.3M$14.3M—————$12.7M$13.8M$10.4M
Goodwill $865.3M$419.3M$278.8M$269.1M$246.4M$232.4M$238.5M$185.8M$86.2M$103.4M
Other intangibles $271.0M$118.2M$71.6M$76.9M$82.8M$87.0M$103.0M$86.9M$103.5M$108.1M
Total assets $2.22B$1.35B$933.4M$966.2M$895.7M$843.1M$728.7M$513.0M$490.6M$350.0M
Accounts payable $195.9M$106.1M$59.9M$49.6M$44.0M$36.1M$27.3M$4.5M$3.8M$1.4M
Short-term debt $47.9M$9.4M$19.5M$619.0K$780.0K$10.9M$9.5M$0—$9.9M
Total current liabilities $615.3M$365.6M$218.7M$148.6M$125.9M$122.6M$105.4M$72.0M$109.6M$50.6M
Long-term debt $990.9M$425.3M$258.9M$203.4M$182.9M$230.2M$232.2M$0——
Total liabilities $1.66B$840.7M$522.6M$407.7M$356.2M$382.3M$367.7M$106.3M$154.3M$99.6M
Retained earnings $308.4M$286.3M$243.1M$182.4M$90.4M$80.3M$31.9M$17.8M$1.7M-$773.3K
Total equity $779.3M$712.7M$616.7M$544.3M$454.1M$329.5M$192.3M$181.5M$164.2M$87.6M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $114.6M$52.2M$68.2M$82.1M$70.3M$46.2M$13.7M$25.5M$51.8M$21.9M
Depreciation and amortisation $45.7M$27.9M$17.7M$17.5M$17.5M$18.4M$18.3M$19.3M$19.1M$18.1M
Stock-based compensation $38.6M$34.5M$22.0M$16.1M$6.7M$3.4M$1.5M$1.4M$2.7M—
Capital expenditure $10.1M$8.0M$28.5M$22.9M$19.2M$1.2M$1.0M$1.2M$2.1M$3.3M
Investing cash flow -$539.0M-$192.4M-$65.5M-$7.1M$16.5M$95.5M-$180.6M-$25.2M$26.7M-$9.0M
Financing cash flow $569.3M$135.1M$3.4M-$20.1M-$47.7M-$51.7M$163.3M-$11.2M-$15.0M-$17.1M
Dividends paid $7.9M$4.0M$62.1M$14.0M$31.1M$51.3M$61.7M$17.8M$10.4M$26.7M
Buybacks $25.6M$900.0K$100.0M$9.2M$5.7M$537.0K$7.6M$5.0M$3.2M$517.5K

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001104659-26-044536.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 1B 2B 3B 4B Revenue, FY2016: 305.9M Gross profit, FY2016: 51.2M Net income, FY2016: 11.5M Revenue, FY2017: 356.4M Gross profit, FY2017: 82.9M Net income, FY2017: 25.8M Revenue, FY2018: 519.9M Gross profit, FY2018: 158.8M Net income, FY2018: 10.8M Revenue, FY2019: 560.6M Gross profit, FY2019: 92.8M Net income, FY2019: 14.1M Revenue, FY2020: 687.2M Gross profit, FY2020: 148M Net income, FY2020: 37.7M Revenue, FY2021: 773.9M Gross profit, FY2021: 177.8M Net income, FY2021: 46M Revenue, FY2022: 1.1B Net income, FY2022: 46M Revenue, FY2023: 1.4B Net income, FY2023: 58M Revenue, FY2024: 2B Net income, FY2024: 50M Revenue, FY2025: 3.2B Net income, FY2025: 24M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $305.9M $356.4M $519.9M $560.6M $687.2M $773.9M $1.14B $1.39B $2.03B $3.18B
Gross profit $51.2M $82.9M $158.8M $92.8M $148.0M $177.8M — — — —
Net income $11.5M $25.8M $10.8M $14.1M $37.7M $46.0M $46.0M $58.0M $50.0M $24.0M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Regulation FD disclosure Item 7.01
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Officer or director change Item 5.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Officer or director change Item 5.02
  • Regulation FD disclosure Item 7.01
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 8742

TickerCompanyMarket capP/ERevenue growth
BAH Booz Allen Hamilton Holding Corp $9.42B 11.4x -6.4%
G Genpact LTD $6.86B 13.0x 6.6%
FCN FTI CONSULTING, INC $4.34B 19.1x 2.4%
EXPO EXPONENT INC $3.68B 37.4x 4.2%
HURN Huron Consulting Group Inc. $3.17B 33.5x 11.9%
ICFI ICF International, Inc. $1.69B 19.1x -7.3%
BWMN Bowman Consulting Group Ltd. $742.5M 58.7x 14.9%
ONT Onterris, Inc. $520.8M — 19.3%